408 related articles for article (PubMed ID: 28115846)
1. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
[TBL] [Abstract][Full Text] [Related]
2. Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization Via Inhibition of VEGF Production.
Miyagawa T; Chen ZY; Chang CY; Chen KH; Wang YK; Liu GS; Tseng CL
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32354067
[TBL] [Abstract][Full Text] [Related]
3. Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief.
Huang HY; Wang MC; Chen ZY; Chiu WY; Chen KH; Lin IC; Yang WV; Wu CC; Tseng CL
Int J Nanomedicine; 2018; 13():7251-7273. PubMed ID: 30510416
[TBL] [Abstract][Full Text] [Related]
4. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
[TBL] [Abstract][Full Text] [Related]
5. Functional Peptide-Loaded Gelatin Nanoparticles as Eyedrops for Cornea Neovascularization Treatment.
Chu YC; Fang HW; Wu YY; Tang YJ; Hsieh EH; She Y; Chang CY; Lin IC; Chen YJ; Liu GS; Tseng CL
Int J Nanomedicine; 2023; 18():1413-1431. PubMed ID: 36992821
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea].
Wu LQ; Lu M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 44(1):15-23. PubMed ID: 25851970
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.
Lu Y; Zheng Y; Ai J; Xu X
Discov Med; 2016 May; 21(117):349-61. PubMed ID: 27355331
[TBL] [Abstract][Full Text] [Related]
9. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
[TBL] [Abstract][Full Text] [Related]
10. Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization.
Kim H; Choi JS; Kim KS; Yang JA; Joo CK; Hahn SK
Acta Biomater; 2012 Nov; 8(11):3932-40. PubMed ID: 22824530
[TBL] [Abstract][Full Text] [Related]
11. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
Gore A; Horwitz V; Cohen M; Gutman H; Cohen L; Gez R; Kadar T; Dachir S
Exp Eye Res; 2018 Jun; 171():183-191. PubMed ID: 29548928
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin-3-gallate, reduces corneal damage secondary from experimental grade II alkali burns in mice.
Gulias-Cañizo R; Lagunes-Guillén A; González-Robles A; Sánchez-Guzmán E; Castro-Muñozledo F
Burns; 2019 Mar; 45(2):398-412. PubMed ID: 30600126
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
Koh CH; Lee HS; Chung SK
Cornea; 2014 May; 33(5):527-32. PubMed ID: 24608256
[TBL] [Abstract][Full Text] [Related]
14. A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo.
Ge H; Tian P; Guan L; Yin X; Liu H; Xiao N; Xiong Y; Luo X; Sun Y; Qi D; Ni S; Liu P
Exp Eye Res; 2013 Jul; 112():10-20. PubMed ID: 23562678
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rho-Associated Kinase Prevents Pathological Wound Healing and Neovascularization After Corneal Trauma.
Sijnave D; Van Bergen T; Castermans K; Kindt N; Vandewalle E; Stassen JM; Moons L; Stalmans I
Cornea; 2015 Sep; 34(9):1120-9. PubMed ID: 26075454
[TBL] [Abstract][Full Text] [Related]
16. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
[TBL] [Abstract][Full Text] [Related]
17. Platelet-camouflaged nanococktail: Simultaneous inhibition of drug-resistant tumor growth and metastasis via a cancer cells and tumor vasculature dual-targeting strategy.
Jing L; Qu H; Wu D; Zhu C; Yang Y; Jin X; Zheng J; Shi X; Yan X; Wang Y
Theranostics; 2018; 8(10):2683-2695. PubMed ID: 29774068
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye.
Tsai CH; Hoang LN; Lin CC; Pan LC; Wu CL; Lin IC; Wang PY; Tseng CL
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745825
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.
Cui Y; Zhang C; Luo R; Liu H; Zhang Z; Xu T; Zhang Y; Wang D
Int J Nanomedicine; 2016; 11():5671-5682. PubMed ID: 27895477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
